Skip Navigation
NIAID > Labs & Scientific Resources > Microbiology and Infectious Diseases Resources > DAIDS Clinical Research Policies

Division of AIDS (DAIDS) Clinical Research Policies and Standard Procedures Documents

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • Pin it
  • submit to Google +

List of DAIDS Acronyms

AE Adverse Event
CAB Community Advisory Board
CFR Code of Federal Regulations
CRF Case Report Forms
COI Conflict of Interest
CRO Clinical Research Organization
CRS Clinical Research Site
DAIDS Division of AIDS
DRTE DAIDS Regional Training Event
DSMB Data Safety Monitoring Board
DSMP Data Safety Monitoring Plan
EAE Expedited Adverse Event
US FDA Food and Drug Administration
FWA Federalwide Assurance
EC Ethics Committee
GCP Good Clinical Practices
GCLP Good Clinical Laboratory Practices
US DHHS Department of Health and Human Services
HIPAA Health Insurance Portability and Accountability Act
HRPP Health Research Protections Program
HSP Human Subject Protections
IND Investigational New Drug Application
IB Investigator's Brochure
ICH International conference on Harmonization
IO Institutional Official
IoR Investigator of Record
IRB Institutional Review Board
LAR Legal Authorized Representative
LoA Letter of Amendment
MO Medical Officer
NIAID National Institute of Allergy and Infectious Diseases
NIH National Institutes of Health
OCSO Office of Clinical Site Oversight
OHRP Office for Human Research Protections
OPCRO Office for Policy in Clinical Research Operations
ORI Office of Research integrity
PI Principal Investigator
PO Program Officer
PRO Protocol Registration Office
QA Quality Assurance
QI Quality Improvement
RA Regulatory Authority
RSC Regulatory Support Contract
SACHRP Secretary's Advisory Committee on Human Research Protection
SAE Serious Adverse Event
SOP Standard Operating Procedure

Last Updated October 20, 2011

Last Reviewed October 20, 2011